Goodpasture's disease: Antiglomerular basement membrane disease

Nephrology

Volumn 9, Issue 2, 2004, Pages 49-51

  Erlich, Jonathan H ^a   Sevastos, Jacob ^a   Pussell, Bruce A ^a  

^a PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOIMMUNE DISEASE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; EDITORIAL; GLOMERULONEPHRITIS; GLOMERULUS BASEMENT MEMBRANE; GOODPASTURE SYNDROME; HEMOPTYSIS; HUMAN; INCIDENCE; KIDNEY FAILURE; KIDNEY GRAFT; LABORATORY TEST; PATHOGENESIS; PRIORITY JOURNAL;

ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; AUTOANTIBODIES; BASEMENT MEMBRANE; GLOMERULONEPHRITIS; HEMORRHAGE; HUMANS; KIDNEY GLOMERULUS; LUNG DISEASES;

EID: 1942467831     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2004.00244.x     Document Type: Editorial

References (22)

1. Kalluri R, Wilson CB, Weber M et al. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome. J. Am. Soc. Nephrol. 1995; 6: 1178-85.
2. Derry CJ, Pusey CD. Tissue-specific distribution of the Goodpasture antigen demonstrated by 2-D electrophoresis and western blotting. Nephrol. Dial. Transplant. 1994; 9: 355-61.
3. Goodpasture EW. The significance of certain pulmonary lesions in relation to the etiology of Influenza. Am. J. Med. Sci. 1918; 158: 863-70.
4. Kluth DC, Rees AJ. Anti-glomerular basement membrane disease. Kidney Int. 1999; 10: 2446-53.
5. Shah MK, Hugghins SY. Characteristics and outcomes of patients with Goodpasture's syndrome. South Med. J. 2002; 95: 1411-18.
6. Li FK, Tse KC, Lam MF. Incidence and outcome of antiglomerular basement membrane disease in Chinese. Nephrology 2004; 9: 100-4.
7. Bombassei GJ, Kaplan AA. The association between hydrocarbon exposure and anti-glomerular basement membrane antibody-mediated disease (Goodpasture's syndrome). Am. J. Ind. Med. 1992; 21: 141-53.
8. Burns AP, Fisher M, Li P, Pusey CD, Rees AJ et al. Molecular analysis of HLA class II genes in Goodpasture's disease. QJM, 1995; 88 (2): 93-100.
9. Perl SI, Pussell BA, Charlesworth JA, McDonald GJ, Wolnizer M. Goodpasture's (anti-GBM) disease and HLA-DRw2. N. Engl. J. Med. 1981; 305: 463-4.
10. Phelps RG, Jones V, Turner AN, Rees AJ. Properties of HLA class II molecules divergently associated with Goodpasture's disease. Int. Immunol. 2000; 12: 1135-43.
11. Salama AD, Dougan T, Levy JB et al. Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am. J. Kidney Dis. 2002; 39: 1162-7.
12. Kalluri R, Meyers K, Mogyorosi A, Madaio MP, Neilson EG. Goodpasture syndrome involving overlap with Wegener's granulomatosis and anti-glomerular basement membrane disease. J. Am. Soc. Nephrol. 1997; 8: 1795-800.
13. Lerner RA, Glassock RJ, Dixon FJ. The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J. Exp. Med. 1967; 126: 989-1004.
14. Salama AD, Chaudhry AN, Holthaus KA et al. Regulation by CD25+ lymphocytes of autoantigen-specific T-cell responses in Goodpasture's (anti-GBM) disease. Kidney Int. 2003; 64: 1685-94.
15. Reynolds J, Norgan VA, Bhambra U, Smith J, Cook HT, Pusey CD. Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis. J. Am. Soc. Nephrol. 2002; 13: 359-69.
16. Merkel F, Kalluri R, Marx M et al. Autoreactive T-cells in Goodpasture's syndrome recognize the N-terminal NC1 domain on alpha 3 type IV collagen. Kidney Int. 1996; 49: 1127-33.
17. Derry CJ, Ross CN, Lombardi G et al. Analysis of T cell responses to the autoantigen in Goodpasture's disease. Clin. Exp. Immunol. 1995; 100: 262-8.
18. Tipping PG, Kitching AR, Huang XR, Mutch DA, Holdsworth SR. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur. J. Immunol. 1997; 27: 530-7.
19. Johnson JP, Moore Jr J, Austin 3rd HA, Barlow JE, Antonovych TT, Wilson CB. Therapy of anti-glomerular basement membrane antibody disease: Analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine (Baltimore), 1985; 64: 219-27.
20. Pusey CD, Lockwood CM, Peters DK. Plasma exchange and immunosuppressive drugs in the treatment of glomerulonephritis due to antibodies to the glomerular basement membrane. Int. J. Artif. Organs 1983; 6 (Suppl. 1): 15-18.
21. Dahlberg PJ, Kurtz SB, Donadio JV et al. Recurrent Goodpasture's syndrome. Mayo Clin. Proc. 1978; 53: 533-7.
22. Peten E, Pirson Y, Cosyns JP et al. Outcome of thirty patients with Alport's syndrome after renal transplantation. Transplantation 1991; 52: 823-6.